Back

A dangerous mix: life-threatening arrhythmias during concurrent Flecainide and RAF/MEK inhibitors intake.

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology 2 Cardio-Oncology HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Giulia Nangeroni

San Luigi Gonzaga University Hospital, Orbassano (Italy)

3 More presentations in this session

Presentation thumbnail
Genuine biatrial myxoma- the rarest form of myxoma
Doctor J. Vidovic (Novi Sad, RS)
Slides Video
Presentation thumbnail
Anthracycline-related cardiotoxicity in early puerperium: risk stratification, screening tools and therapeutic options
Doctor M. Guillen Marzo (Tarragona, ES)
Slides Video
Presentation thumbnail
The challenging approach of a young patient with primary intimal sarcoma of the heart
Doctor M. Martinho (Almada, PT)
Slides Video

Access the full session

Session thumbnail
Cardio-oncology 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Drug interctions in cardioncology: a teaching case
thumbnail
Congress Presentation
Cardiotoxicity due to combined target therapy of malignant melanoma with full recovery after its discontinuation
thumbnail
Congress Presentation
The Heart of the Matter- Late cardiotoxicity with severe biventricular dysfunction in a young patient with non-Hodgkin Lymphoma treated with R-CHOP

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources